Victoria Hospital
Welcome,         Profile    Billing    Logout  
 8 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cook, Robert L
NCT05090267: The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study

Recruiting
N/A
80
US
Probiotic Supplement, Transcutaneous Vagal Nerve Stimulation (tVNS)
University of Florida, University of Miami, University of Louisville, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Exegi Pharma, LLC, Soterix Medical
Cognition, Gut Microbiome
06/26
06/26
Campbell, Victoria
SELECT MDS-1, NCT04797780 / 2020-004528-40: Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

Recruiting
3
550
Europe, Canada, US, RoW
Tamibarotene, SY-1425, Placebo, Azacitidine
Syros Pharmaceuticals
Myelodysplastic Syndromes
11/24
02/29
FiTNEss, NCT03720041 / 2018-003590-10: Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma

Recruiting
3
740
Europe
R1: Ixazomib, Lenalidomide, Dexamethasone (IRD) induction therapy - reactive arm, Ninlaro, Revlimid, R1: Ixazomib, Lenalidomide, Dexamethasone (IRD) induction therapy - adaptive arm, R2: Lenalidomide plus placebo maintenance, R2: Lenalidomide + ixazomib maintenance
University of Leeds, Cancer Research UK, Takeda, Celgene
Multiple Myeloma
12/24
12/24
CL1-65487-003, NCT04742101 / 2020-003061-19: Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Active, not recruiting
1/2
57
Europe, RoW
S65487 and azacitidine
Institut de Recherches Internationales Servier, ADIR, a Servier Group company
Acute Myeloid Leukemia
09/24
04/25
CCS1477-02, NCT04068597 / 2019-000104-15: Study to Evaluate CCS1477 in Haematological Malignancies

Recruiting
1/2
250
Europe, US
CCS1477, Pomalidomide, Dexamethasone, Azacitidine, Venetoclax
CellCentric Ltd.
Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma, Higher-risk Myelodysplastic Syndrome, Peripheral T Cell Lymphoma
06/25
06/25
Patterson, Catherine
PHADE, NCT05403853: A Performance Evaluation of the Lumiradx Point of Care HbA1c Device

Completed
N/A
334
Europe
Venepuncture, Fingerstick
LumiraDx UK Limited
Diabetes
10/22
10/22
Raman, Rajendra
No trials found

Download Options